Grace Therapeutics, Stock Market Value
| GRCE Stock | 3.37 0.00 0.00% |
| Symbol | Grace |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Grace Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Grace Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Grace Therapeutics,.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Grace Therapeutics, on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Grace Therapeutics, or generate 0.0% return on investment in Grace Therapeutics, over 30 days. Grace Therapeutics, is related to or competes with Ambev SA, Oatly Group, Willamette Valley, Sonos, JD Sports, Playtika Holding, and Canlan Ice. Grace Therapeutics, is entity of United States More
Grace Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Grace Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Grace Therapeutics, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.38 | |||
| Information Ratio | 0.0954 | |||
| Maximum Drawdown | 25.57 | |||
| Value At Risk | (4.75) | |||
| Potential Upside | 9.42 |
Grace Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Grace Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Grace Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Grace Therapeutics, historical prices to predict the future Grace Therapeutics,'s volatility.| Risk Adjusted Performance | 0.1022 | |||
| Jensen Alpha | 0.5851 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.1307 | |||
| Treynor Ratio | (2.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Grace Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Grace Therapeutics, Backtested Returns
Grace Therapeutics, appears to be very risky, given 3 months investment horizon. Grace Therapeutics, holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of standard deviation over the last 3 months. By evaluating Grace Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please utilize Grace Therapeutics,'s risk adjusted performance of 0.1022, and Market Risk Adjusted Performance of (2.24) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Grace Therapeutics, holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of -0.25, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Grace Therapeutics, are expected to decrease at a much lower rate. During the bear market, Grace Therapeutics, is likely to outperform the market. Please check Grace Therapeutics,'s sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether Grace Therapeutics,'s current trending patterns will revert.
Auto-correlation | -0.22 |
Weak reverse predictability
Grace Therapeutics, has weak reverse predictability. Overlapping area represents the amount of predictability between Grace Therapeutics, time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Grace Therapeutics, price movement. The serial correlation of -0.22 indicates that over 22.0% of current Grace Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.22 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Grace Therapeutics, lagged returns against current returns
Autocorrelation, which is Grace Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Grace Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Grace Therapeutics, returns to help us make a trade decision. For example, suppose you find that Grace Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Grace Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Grace Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Grace Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Grace Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Grace Therapeutics, Lagged Returns
When evaluating Grace Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Grace Therapeutics, stock have on its future price. Grace Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Grace Therapeutics, autocorrelation shows the relationship between Grace Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Grace Therapeutics,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Grace Therapeutics, is a strong investment it is important to analyze Grace Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grace Therapeutics,'s future performance. For an informed investment choice regarding Grace Stock, refer to the following important reports:Check out Grace Therapeutics, Correlation, Grace Therapeutics, Volatility and Grace Therapeutics, Alpha and Beta module to complement your research on Grace Therapeutics,. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Grace Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.